In re ACTOS Antitrust Litigation

District Court, S.D. New York·Decided November 5, 2022·No. 1:13-cv-09244·Unknown

Opinion

Mier, Sel 2 DOCUMENT UNITED STATES DISTRICT COURT □□□ FILED SOUTHERN DISTRICT OF NEW YORK —_—__— DATE FILED: 11/5/2022 IN RE ACTOS ANTITRUST LITIGATION THIS DOCUMENT RELATES TO: Master File No. 1:13-cv-09244 (RA) (SDA) ALL ACTIONS AMENDED OPINION AND ORDER

STEWART D. AARON, United States Magistrate Judge: Pending before the Court is Plaintiffs’ Letter Motion addressing certain disputes that have arisen concerning the parties’ Deposition Protocol. (Pls.” 10/14/22 Ltr. Mot., ECF No. 438.) The Court resolves these disputes as set forth in the Conclusion below. BACKGROUND This is an antitrust class action by Direct Purchaser and End-Payor Plaintiffs against Defendants Takeda Pharmaceutical Co. Ltd. (“TPCL”), Takeda America Holdings, Inc., Takeda Pharmaceuticals U.S.A., Inc. and Takeda Development Center Americas, Inc. (collectively, “Defendants”). See United Food & Com. Workers Loc. 1776 & Participating Emps. Health & Welfare Fund v. Takeda Pharm. Co. Ltd., 11 F.4th 118, 129 (2d Cir. 2021). Defendant TPCL is a Japanese company with its principal place of business in Osaka, Japan. (See Fourth Am. Compl., ECF No. 255, 4 28.) The other Defendants are incorporated, and have their principal places of business, in the United States. (See id. 4/4] 29-31.) The parties for the most part have agreed to the provisions of a Deposition Protocol to be used in this action. (See Pls.’ 10/14/22 Ltr. Mot. at 1 & Ex. 1.) However, three disputes remain: (1) the number of depositions; (2) the location of depositions of Japanese witnesses; and (3) the

length of interpreter-assisted depositions. (See Pls.’ 10/14/22 Ltr. Mot. at 1-3; see also Defs.’ 10/19/22 Resp., ECF No. 440, at 1-3.) DISCUSSION

I. Number of Depositions A. Legal Standards Rule 30 of the Federal Rules of Civil Procedure requires leave of court for Plaintiffs or Defendants to take more than 10 depositions. See Fed. R. Civ. P. 30(a)(2)(A)(i). The number of depositions also may be expanded by joint stipulation. See Fed. R. Civ. P. 30(a)(2)(A); see also

Fed. R. Civ. P. 29 (governing stipulations about discovery procedure). Rule 26(b)(2)(C) contains factors a court may consider when a party seeks to exceed the ten deposition limit, i.e., whether (1) “the discovery sought is unreasonably cumulative or duplicative, or can be obtained from some other source that is more convenient, less burdensome, or less expensive,” (2) “the party seeking discovery has had ample opportunity to obtain the information by discovery in the action,” and (3) “the proposed discovery is outside the scope permitted by Rule 26(b)(1) [that is,

the discovery must be proportional to the needs of the case].” See Fed. R. Civ. P. 26(b)(2)(C) (governing when court must limit frequency or extent of discovery). B. Analysis Plaintiffs assert that they should be permitted to take 25 depositions of Defendants’ former and current employees and outside counsel, plus 20 hours of 30(b)(6) deposition testimony. (See Pls.’ 10/14/22 Ltr. Mot. at 1-2; Pls.’ 10/20/22 Reply, ECF No. 440, at 1-2.) In

support of their assertion, Plaintiffs point to the 25 custodians from whom Defendants produced documents, the 29 individuals identified by Defendants in their interrogatory responses and the 35 current and former employees of Defendants who Plaintiffs “initially identified . . . as potential deponents.” (See id.) Defendants assert that Plaintiffs should be limited to 12 depositions of Defendants’ former and current employees and outside counsel, inclusive of a Rule 30(b)(6)

deposition. (See Defs.’ 10/19/22 Resp., ECF No. 440, at 1-2.) Defendants, however, acknowledge that they initially had proposed 15 depositions.1 (See id. at 1.) The Court, in its discretion, grants Plaintiffs leave to take 15 depositions, i.e., the number as to which Defendants initially had agreed to stipulate. That is, Plaintiffs may take up to 15 depositions of Defendants’ former and current employees and outside counsel, inclusive of a

Rule 30(b)(6) deposition, without further leave of Court. The Court finds that it is premature to decide whether any additional depositions beyond 15 are warranted. “[C]ourts will generally not grant leave to expand the number of depositions until the moving party has exhausted the ten depositions permitted as of right under Rule 30(a)(2)(A) or the number stipulated to by the opposing party.” Gen. Elec. Co. v. Indem. Ins. Co. of N. Am., No. 06-CV-00232 (CFD) (TPS), 2006 WL 1525970, at *2 (D. Conn. May 25, 2006). At

present, the Court cannot ascertain whether any testimony sought from witnesses in excess of 15 would be unreasonably cumulative or duplicative. Once Plaintiffs have exhausted the 15- deposition limit, they may seek leave to take additional depositions. In that regard, the Court notes that “[t]he mere fact that there are several individuals who may possess relevant information does not necessarily entitle a party to examine each of them.” Raba v. Suozzi, No. 06-CV-01109 (DRH) (AKT), 2006 WL 8435603, at *1 (E.D.N.Y. Nov. 17, 2006); see also Commodity

1 Defendants have limited themselves to taking ten depositions of Plaintiffs as a group. (See Dep. Protocol, ECF No. 438-1, ¶ 15.) Futures Trading Com’n v. Commodity Inv. Group, Inc., No. 05-CV-05741 (HB), 2005 WL 3030816 (S.D.N.Y. Nov. 10, 2005) (“Although a witness might have discoverable information, a party is not always entitled to depose that individual.”).

Consistent with the Advisory Committee Notes to Rule 30, Defendants’ “deposition under Rule 30(b)(6) [shall], for purposes of [the 15-deposition] limit, be treated as a single deposition even though more than one person may be designated to testify.” See Fed. R. Civ. P. 30, Advisory Committee Notes, 1993 Amendment. The parties shall meet and confer regarding the topics to be addressed at Defendants’ Rule 30(b)(6) deposition and the length of such deposition. If the

parties are unable to agree after good faith negotiations, they may make an appropriate application to the Court. II. Location Of Depositions Of Japanese Witnesses A. Legal Standards “[C]ourts retain substantial discretion to determine the site of a deposition.” Sec. & Exch. Comm’n v. Aly, 320 F.R.D. 116, 118 (S.D.N.Y. 2017) (citing Lewis v. Madej, No. 15-CV-02676 (DLC),

2016 WL 590236, at *3 (S.D.N.Y. Feb. 11, 2016)). There is a “rebuttable presumption” that the deposition of a defendant will be held where the defendant resides. See id. “[A] plaintiff may only overcome this presumption by showing ‘peculiar’ circumstances favoring depositions at a different location.” Six West Retail Acquisition v. Sony Theatre Mgmt. Corp., 203 F.R.D. 98, 106 (S.D.N.Y. 2001) (citation omitted). The presumption also “can be overcome by a showing that factors of cost, convenience, and litigation efficiency militate in favor of holding the deposition

somewhere other than the district of the deponent’s residence or place of business.” Devlin v. Transportation Commc’ns Int’l Union, No. 95-CV-00752 (JFK) (JCF), 2000 WL 28173, at *3 (S.D.N.Y. Jan. 14, 2000). B. Analysis

Plaintiffs seek to have “certain witnesses residing in Japan available for deposition in the U.S.

Free access — add to your briefcase to read the full text and ask questions with AI

In re ACTOS Antitrust Litigation, (S.D.N.Y. 2022).

In re ACTOS Antitrust Litigation (In re ACTOS Antitrust Litigation) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Custom Form Manufacturing, Inc. v. Omron Corp.
196 F.R.D. 333 (N.D. Indiana, 2000)
Securities & Exchange Commission v. Aly
320 F.R.D. 116 (S.D. New York, 2017)